117 results about "Expectorant" patented technology

The present invention relates to a compound represented by the formula (I),wherein all symbols are as defined in the description,a salt thereof, a solvate thereof, or a prodrug thereof, which has a leukotriene receptor antagonistic activity which is expected to be more effective than those of the leukotriene receptor antagonists currently used in clinical trials. Therefore, it is useful as an agent for the prevention and / or treatment of a leukotriene-mediated disease such as a respiratory diseases such as bronchial asthma, chronic obstructive pulmonary disease, pulmonary emphysema, chronic bronchitis, pneumonia (e.g. interstitial pneumonia etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), or the like, or as an expectorant or an antiitussive.

The invention provides an inhalant composition for treating chronic obstructive pulmonary diseases. Active ingredients in the composition include pyruvic acid, medicinal pyruvate, a pyruvic acid medicinal precursor or a composition thereof. The chronic obstructive pulmonary diseases include chronic bronchitis and emphysema. Compared with the prior art, the inhalant composition used for treating chronic obstructive pulmonary diseases has the advantages that 1, the inhalant can directly enter the lung in a highly targeting manner, can directly act on the focus of the lung in a highly targeting manner, and does not participate in body metabolism; 2, the medicinal pyruvate, the pyruvic acid precursor and the pyruvic acid in the composition are nutrient substances, and are abundant in the blood, so that the toxic and side effects are reduced, and higher safety and medicament stability are achieved; 3, as an antioxidant, sodium pyruvate differs from antibiotics, expectorants and sterol medicaments, acts more comprehensively, and is better in effect.

The invention provides pharmaceutical composition for respiratory diseases and a preparation process thereof, in particular to pharmaceutical composition and a preparation process and application thereof. The pharmaceutical composition comprises active ingredients, namely levodropropizine and carbocysteine, and pharmaceutically acceptable accessories. Compared with commonly used existing antitussive drugs or expectorants in the market, the pharmaceutical composition has more evident effect of cough relieving and fewer adverse reactions and has certain social benefit and economic benefit.

Kits providing a combination of one or more pharmaceutical information comprising one or more agent(s) for the treatment or alleviation of symptoms commonly associated with a cold and an immunonutritional composition comprising immunonutritional agent and methods of using these kits are described. The kits provide both the pharmaceutical agent(s) and the immunonutritional agent in a convenient form for administration. The kit typically includes instruction for coordinating the administration of the pharmaceutical formulation with the administration of the immunonutritional composition. The preferred immunonutritional agents are compounds that contain a pharmaceutically acceptable form of zinc, such as zinc acetate, zinc gluconate, zinc gluconate glycine, and zinc sulfate. Preferably the kit contains multiple dosage forms containing the immunonutritional composition. In the most preferred embodiment, the immunonutritional composition is in the form of a lozenge. Suitable pharmaceutical agents include but are not limited to antihistamines, decongestants, anticholinergics, antitussives, analgesics, mucolytics, expectorants, and combinations thereof. The pharmaceutical formulations may be in any suitable dosage form, including forms which provide controlled release of the pharmaceutical agent, including immediate, sustained, modified, delayed or pulsed release pharmacokinetic mechanism or a combination thereof. The combined treatment requires administration of both the pharmaceutical formulation(s) for the treatment of symptoms commonly associated with a cold and the administration of the immunonutritional composition, which supplies nutritional support for the patient's innate immune response to the presence of infectious organisms.